Dayquil And Nyquil Severe Plus Vicks Vapocool
NDC Package 37000-534-48
Package Information
Dayquil And Nyquil Severe Plus Vicks Vapocool is a . Marketed by The Procter & Gamble Manufacturing Company, this product is identified by NDC 37000-534 and is authorized under FDA application M012.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 37000 - The Procter & Gamble Manufacturing Company
- 37000-534 - Dayquil And Nyquil Severe Plus Vicks Vapocool
- 37000-534-48 - 1 KIT in 1 PACKAGE * 2 TABLET in 1 BLISTER PACK * 2 TABLET, COATED in 1 BLISTER PACK
- 37000-534 - Dayquil And Nyquil Severe Plus Vicks Vapocool
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (37000-534). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 37000-534-48 identifies a specific commercial package of 1 kit in 1 package * 2 tablet in 1 blister pack * 2 tablet, coated in 1 blister pack of Dayquil And Nyquil Severe Plus Vicks Vapocool Cold And Flu, labeled by The Procter & Gamble Manufacturing Company. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by The Procter & Gamble Manufacturing Company on August 01, 2018. The current certification is valid through March 22, 2023.
How is this The Procter & Gamble Manufacturing Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 37000053448. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.